logo
What US economic madness means for the rest of the world

What US economic madness means for the rest of the world

Irish Times2 days ago
Tariffs
are a major own goal for the
US
– and also bad for the rest of the world.
Tearing up previous agreements on trade casts doubt on whether any new agreement with the US administration will stick. The
EU
will still try to reach a settlement with
Donald Trump
by the end of the month, but there is no certainty that reason will prevail. If there is no agreement, we will face a very disruptive and damaging period of trade wars. Even if there is a deal, it will represent a significantly worse outcome for the EU and the US economies than the status quo.
Naturally, all our attention is focused on the trade issue, as it will have an immediate impact on both sides of the Atlantic. However, the US budget, passed by the US Congress earlier this month, referred to as the 'One Big Beautiful Act', has even more serious long-term implications for the US economy.
First, the US budget provides for a huge tax give-away for the better-off. Second, it plans to cut healthcare for many millions of Americans in 2027, just after the next congressional elections. Third, the combined effect of the changes in tax and expenditure mean the US government deficit will remain at about 6 per cent of GDP for the next decade, even under optimistic growth assumptions.
READ MORE
The independent Congressional Budget Office forecast that the US debt, currently at 120 per cent of GDP, will as a result rise to rise to about 140 per cent over the coming decade. In the OECD area, only Italy, Greece and Japan are currently experiencing this level of indebtedness.
David McWilliams on how 'big incentives' to build could save Dublin city
Listen |
36:51
The White House, akin to the short-lived regime of
Liz Truss
in the UK, proclaims a different reality, asserting that economic growth will solve the budgetary problems, keeping the debt in check. All serious economists in the US indicate that this is a fairy tale.
We have learned the hard way that if debt reaches current US levels, stopping a slide into insolvency is very painful. There is no prospect of the US getting out of the debt mess by defaulting – they can just print dollars. Trying to square the circle of continuing to borrow big, while paying rising interest bills, can only be achieved in one of two ways – through inflation, or by what is termed financial repression. While the latter is less likely, it would involve the US government forcing the rest of the US economy to lend to it. However, if the US government hoovered up all national savings, this would severely impact on investment and growth, as has happened in Japan.
[
Will Donald Trump fire Jerome Powell? 'I don't rule out anything. But it's unlikely. Unless …'
Opens in new window
]
The US budgetary problems matter for the rest of the world because most countries, including China, hold much of their financial reserves in the form of US government debt.
In the early 1970s under
Richard Nixon
, when US borrowing was out of control, inflation was allowed to dramatically increase, peaking at 11 per cent in 1974. This very rapidly eroded the value of the US debt, which also represented much of the financial reserves held by the rest of the world. In response to reproaches from US creditors, the then US treasury secretary John Connally
responded with Trump-like arrogance: 'Our money, your problem'. This pattern was repeated under
Ronald Reagan
, and it is highly likely that under Trump a burst of inflation will again be needed to erode the US government debt, much of which represents foreigners' reserves.
Already, worry about this has led to a fall of 10 per cent in the value of the dollar compared to the euro since Trump took office. For our exports to the US, the 10 per cent increase in their cost in dollars comes as a double whammy on top of the 10 per cent tariff rate already imposed.
[
'It's Maga, baby': Trump's 50% tariff threat on Brazil marks unprecedented interference in foreign courts
Opens in new window
]
Other countries won't be as ready to lend to the US when the value of their bond holdings are being eroded. To date, the interest rate paid by the US government for long-term borrowing has not risen significantly, but it is likely to do so over coming years, given the growing risk that the inflation solution will be adopted.
With rapidly rising debt, there's increasing temptation for the US to allow inflation by persuading the US central bank,
the 'Fed'
, to reduce short-term interest rates, rather than choking off inflation through higher interest rates. To date, Trump's threats to force the Fed to reduce interest rates have fallen on deaf ears.
Trump may continue to try to strong-arm current Fed chairman
Jerome Powell
, but will doubtless replace him at the end of his term next year with a less independent, more pliant, nominee.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Trump says he will use import restrictions to reduce drug prices
Trump says he will use import restrictions to reduce drug prices

RTÉ News​

time2 hours ago

  • RTÉ News​

Trump says he will use import restrictions to reduce drug prices

US President Donald Trump said he would use import restrictions to force foreign suppliers to cut drug prices and that pharmaceutical companies would have a lot of problems if they did not agree to bring prices down. Speaking at the White House at an event with Republican politicians, Mr Trump pledged to reduce what consumers must pay for prescription drugs. The US is the biggest market by sales for big pharma companies, and Europe and the US have interconnected supply chains for medicines with the pharmaceutical sector employing around 45,000 people in Ireland. Total Irish exports were valued at €223.8 billion last year, with roughly one third going to the US. Of the €72.6 billion in US imports from Ireland, approximately €58 billion relates to pharmaceuticals and chemicals leaving Ireland. Pharmaceutical companies have previously expressed concern about the threat of tariffs and what they would mean for investment in Europe. In April, a number of pharmaceutical companies sent a letter to EU Commission President Ursula von der Leyen, warning that the EU could lose €100bn in new investment unless there is a rethinking on regulation and pricing. The letter was sent by around 30 CEOs of some of the largest pharmaceutical companies in the world.

Davy to focus more investment on European markets amid volatility in US
Davy to focus more investment on European markets amid volatility in US

Irish Examiner

time4 hours ago

  • Irish Examiner

Davy to focus more investment on European markets amid volatility in US

Despite the fallout from US president Donald Trump's trade war being 'much milder' than expected, Irish wealth management firm Davy still plans to 'bias away' from US markets as high valuations make it 'more vulnerable to correction if the economic picture changes'. In the firm's latest Wealth View report for the third quarter of the year, it noted that US equity markets have rebounded from the turbulence caused by Mr Trump's tariff announcement on April 2 and that Europe has shown strength with markets across the bloc ahead of where they were last year. It attributed the rebound in the US markets to investor confidence that the administration would retreat from policies that disrupt the market, and by optimism surrounding the stimulative effects of the One Big Beautiful Bill Act passed recently by the US Congress. The report said that the economic fallout from the trade war has been 'much milder' than expected 'as tariffs have been paused or have yet to make an impact'. 'Unfortunately, the better-than-expected news is mostly factored into equity valuations already, which have recovered rapidly to multi-year highs, led by the US and the tech sector,' the report said. We note that high valuations are not enough to move markets on their own, but they do make a market more vulnerable to correction if the economic picture changes. "For this reason, we maintain our bias away from the US and towards Europe and emerging markets.' Davy said that the eurozone and China are currently doing better than forecasted but the UK remains in a tight spot. The rising value of the euro against the dollar has also been a significant development for investors this year, according to Davy. However, it cautioned that too strong a euro could cause issues for the European Central Bank (ECB). 'A weaker dollar will push up prices in the US just when tariffs may be doing the same. Also, foreign central banks may push back if the exchange rate interferes with their mandates. For example, the ECB has identified €1.20 as a threshold for concern for the euro-dollar exchange rate,' the report said. The report said that while the S&P 500 hit new highs in June, it has delivered negative returns, after accounting for the depreciation of the dollar. In the first half of the year, the European Stoxx 600 index beat the S&P 500 by the biggest margin this century. Chief investment officer at Davy, Donough Kilmurray, said the last six months show the importance of diversification across investment portfolios. 'We are investing through a period of unusually high uncertainty, and all sorts of assets have played a role already this year, from less-favoured equities to alternative strategies to gold, both by adding to returns and by cushioning declines,' he said. 'Given the incumbent in the White House, we intend to stay diversified.' In a bid to protect against this volatility, Davy has made changes to its Strategic Asset Allocation (SSA) which shifts how it manages long-term portfolios. These include reducing equity exposure in cautious and moderate portfolios, increasing allocation to bonds to help protect against market volatility and macroeconomic risks, as well as increasing the use of alternative investments, including hedge fund-style strategies and gold. Read More Irish economy to grow by more than 4% through 2027 despite heightened geopolitical tensions

AstraZeneca says new facility in Dublin on target for 2026 completion
AstraZeneca says new facility in Dublin on target for 2026 completion

Irish Examiner

time4 hours ago

  • Irish Examiner

AstraZeneca says new facility in Dublin on target for 2026 completion

Drug maker AstraZeneca has announced plans to invest $50bn (€42.6bn) in the US over the next five years amid the looming threat of US president Donald Trump's trade tariffs. The firm said the investment will fund a new "state-of-the-art" manufacturing facility in Virginia - set to be its largest single manufacturing investment in the world. It will also expand research and development (R&D) and cell therapy manufacturing in Maryland, Massachusetts, California, Indiana and Texas. In 2021 AstraZeneca said it was investing €300m to establish a next-generation active pharmaceutical ingredient (API) manufacturing facility for small molecules in Dublin. Those plans are unaffected by the US announcement, a spokesperson told the Irish Examiner. "In line with our plans, the construction of our synthetic drug substance commercialisation facility in Ireland is scheduled for completion in 2026," said the spokesperson. The US announcement marks the latest by a global pharmaceutical giant to expand its footprint in the US as Mr Trump has threatened to impose tariffs of up to 20% on drug imports in an effort to increase manufacturing in America and drive down costs for Americans. AstraZeneca said the mammoth investment will create tens of thousands of jobs across the US, "powering growth and delivering next-generation medicines for patients in America and worldwide". The Anglo-Swedish group, which is listed on the FTSE 100, said the investment will also help it towards the group's target of reaching $80bn (€60bn) in revenues by 2030, with half of this is expected to come from the US, it added. Despite being headquartered in the UK, America is AstraZeneca's largest market, where it employs more than 18,000 staff and makes 42% of total group sales. It already has 19 R&D, manufacturing and commercial sites across the country.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store